Mexico's Televisa cuts 2025 investment budget, shares trim gains
Following a conference call on its second-quarter results, shares in the world's biggest producer of Spanish-language content rose 3.6%. The gain pared earlier increases, as the shares had climbed by as much as 7.6% earlier in the day.
"While we expect CAPEX deployment to accelerate during the second half of the year, we are cutting our CAPEX budget," Televisa Co-Chief Executive Alfonso de Angoitia told the conference, explaining that successful negotiations with suppliers have resulted in more favorable terms for the company.
On Tuesday the broadcaster reported a net profit of 474.5 million pesos ($25.3 million) for the second quarter, a rebound from the 25.6 million peso loss in the year-ago period.
The quarterly profit was largely supported by lower costs, despite a decrease in subscriptions, particularly for its satellite TV unit, SKY.
The company's revenues totaled 14.73 billion pesos, a 6% decrease from the same period last year. However, Angoitia added that revenues would have remained unchanged when excluding the impact of the Mexican peso's depreciation.
Peso weakened 2.6% from the end of June last year to the end of June this year.
($1 = 18.7654 pesos at end-June)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
Graco (GGG): A Quiet Performer Worth a Buy and Hold Strategy
Graco Inc. (NYSE:GGG) is included among the 10 Best Dividend Stocks to Buy and Hold Forever. A technician in a factory controlling the production of fluid and powder materials. Graco Inc. (NYSE:GGG) is an American industrial firm that focuses on designing and producing fluid-handling systems and equipment. The company reported strong earnings in the second quarter of 2025. Its revenue came in at $571.8 million, which showed a 3.3% growth from the same period last year. However, Graco Inc. (NYSE:GGG) experienced a decline in organic sales within its Contractor segment, primarily due to weakness in the North American construction sector, cautious spending by distribution channels and contractors, and decreased customer traffic in home improvement stores. This downturn in organic revenue was largely concentrated in the Americas, while the EMEA and Asia Pacific regions reported volume growth. Meanwhile, sales of powder finishing equipment remained strong during the quarter, supported by increased activity in the Chinese market. Graco Inc. (NYSE:GGG)'s cash position for FY25 remained strong. YTD, the company generated an operating cash flow of $308 million, which was up by $50 million from the prior-year period. Due to this consistent cash position, GGG was able to raise its payouts for 24 consecutive years, which makes it one of the best dividend stocks to buy and hold. The company currently pays a quarterly dividend of $0.275 per share and has a dividend yield of 1.31%, as of July 31. While we acknowledge the potential of GGG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None.
Forbes
33 minutes ago
- Forbes
How Will VRTX Stock React To Its Upcoming Earnings?
Vertex Pharmaceuticals (NASDAQ:VRTX) is set to release its earnings on Monday, August 4, 2025. Over the last five years, Vertex's stock has displayed a trend of positive one-day returns in 58% of cases following earnings announcements. The median positive return has been 3.0%, with a maximum one-day increase of 9.0%. For those trading based on events, recognizing these historical trends can prove advantageous, although actual performance against expectations will be crucial. There are two primary strategies to think about: Analysts anticipate Vertex will disclose earnings of $4.25 per share, generating a revenue of $2.91 billion. This marks a considerable improvement compared to the same quarter last year, which reported a loss of $12.83 per share on sales of $2.65 billion. However, if you are looking for upside with reduced volatility compared to individual stocks, the Trefis High Quality portfolio offers an alternative – having outperformed the S&P 500 and achieved returns exceeding 91% since its launch. View earnings reaction history of all stocks Vertex Pharmaceuticals' Historical Probability of Positive Post-Earnings Return Some insights regarding one-day (1D) post-earnings returns: Further information on observed 5-Day (5D) and 21-Day (21D) returns following earnings is summarized in the table below along with the related statistics. Correlation Between 1D, 5D and 21D Historical Returns A comparatively lower-risk approach (though not effective if the correlation is weak) is to evaluate the correlation between short-term and medium-term returns after earnings, identify the pair that exhibits the strongest correlation, and perform the proper trade. For instance, if 1D and 5D display the highest correlation, a trader can place themselves "long" for the forthcoming 5 days if the 1D post-earnings return is favorable. Below is some correlation data based on both a 5-year and a 3-year (more recent) history. Please note that the correlation 1D_5D indicates the relationship between 1D post-earnings returns and subsequent 5D returns. Discover more about Trefis RV strategy that has outperformed its all-cap stocks benchmark (the combination of all 3, the S&P 500, S&P mid-cap, and Russell 2000), providing strong returns for stakeholders. Additionally, if you're seeking upside with a more stable journey than an individual stock like Vertex Pharmaceuticals, think about the High Quality portfolio, which has outperformed the S&P and achieved >91% returns since its inception.
Forbes
an hour ago
- Forbes
Sell HIMS Stock Ahead of Its Earnings?
Hims & Hers Health (NYSE:HIMS) is set to announce its earnings on Monday, August 4, 2025. Historically, HIMS stock has reacted unfavorably to earnings announcements. Since 2021, the stock has recorded a negative one-day return in 53% of instances after results. The median one-day decline has amounted to -5.8%, with a maximum one-day decrease of -22.3%. For traders focused on events, grasping these historical trends can be beneficial. While the actual results compared to consensus and expectations will be vital, there are two main strategies to contemplate: Analysts expect HIMS to report earnings of $0.23 per share on revenues of $552 million. This would mark substantial growth compared to the same quarter last year, which recorded earnings of $0.16 per share on revenues of $315 million. A possible positive factor for Hims & Hers' sales growth momentum is the reported underperformance of Novo Nordisk's weight loss medication in the U.S. due to the presence of compounded versions. Regarding fundamentals, HIMS has a market capitalization of $15 billion. Over the past twelve months, the company generated $1.8 billion in revenue and was operationally profitable, reporting $110 million in operating profits and a net income of $164 million. However, if you're looking for upside with less volatility than individual stocks, the Trefis High Quality portfolio offers an alternative — it has outperformed the S&P 500 and achieved returns exceeding 91% since its inception. Additionally, see – Is There More Upside For MSFT Stock? Review earnings reaction history of all stocks HIMS Stock Historical Likelihood of Positive Post-Earnings Return Here are some insights on one-day (1D) post-earnings returns: Additional information regarding the observed 5-Day (5D) and 21-Day (21D) returns post earnings is summarized along with the statistics in the table below. HIMS Stock Correlation Between 1D, 5D, and 21D Historical Returns A comparatively lower-risk strategy (though not effective if the correlation is weak) is to understand the relationship between short-term and medium-term returns post earnings, identify a pair that has the highest correlation, and perform the corresponding trade. For instance, if 1D and 5D exhibit the highest correlation, a trader can take a "long" position for the next 5 days if the 1D post-earnings return is positive. Here is some correlation information based on a 5-year and 3-year (more recent) timeframe. Note that the correlation 1D_5D denotes the relationship between 1D post-earnings returns and subsequent 5D returns. Discover more about the Trefis RV strategy that has outperformed its all-cap stocks benchmark (a blend of the S&P 500, S&P mid-cap, and Russell 2000), delivering strong results for investors. Additionally, if you seek upside with a smoother experience than an individual stock like Hims & Hers Health, consider the High Quality portfolio, which has surpassed the S&P and yielded >91% returns since its inception.
